SCHEMBL3169453

SCHEMBL3169453

CC(=O)NCCNc1cc(NCCNC(=O)C=Cc2cccc(C#N)c2)nc(-c2ccc(Cl)cc2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.47
USP2 O75604 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CLK4 Q9HAZ1 1/20 0.47
MAOA P21397 2/20 0.46
MAOB P27338 2/20 0.46
PIM2 Q9P1W9 1/20 0.45
HPGD P15428 2/20 0.40
CYP2C19 P33261 1/20 0.40
HDAC4 P56524 1/20 0.40
MEF2D Q14814 1/20 0.40
ALDH1A1 P00352 2/20 0.39
P4HB P07237 6/20 0.39
ADORA3 P0DMS8 1/20 0.38
PYGL P06737 1/20 0.38
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3169445 1.00 CYP1A2 (0.47) CYP1A2USP2CYP3A4CYP2D6CLK4
SCHEMBL3156177 0.92 CYP1A2 (0.55) CYP1A2USP2CYP3A4CYP2D6CLK4
SCHEMBL3156170 0.92 CYP1A2 (0.55) CYP1A2USP2CYP3A4CYP2D6CLK4
SCHEMBL3166829 0.90 CYP1A2 (0.51) CYP1A2USP2CYP3A4CYP2D6CLK4
SCHEMBL3166815 0.90 CYP1A2 (0.51) CYP1A2USP2CYP3A4CYP2D6CLK4
SCHEMBL3170630 0.87 KMT2A (0.49) CYP1A2CYP3A4CYP2D6PIM2HPGD
SCHEMBL3170642 0.87 KMT2A (0.49) CYP1A2CYP3A4CYP2D6PIM2HPGD
SCHEMBL3175851 0.84 USP2 (0.41) CYP1A2USP2CYP3A4CYP2D6CLK4
SCHEMBL3175844 0.84 USP2 (0.41) CYP1A2USP2CYP3A4CYP2D6CLK4
SCHEMBL3171377 0.84 ALDH1A1 (0.56) HPGDALDH1A1MAPTLMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed